Poor Abbott (and Orion). The marketing execs must have been wetting themselves when they came up with the study acronym for their heart failure hope Simdax (levosimendan).
The SURVIVE study. Sounds great!
Shame about the results.
http://www.forbes.com/technology/sciences/2005/11/16/abbott-heart-failure-1116markets01.html
No comments:
Post a Comment